Stockreport
Delcath Systems up 21% following $2.5M capital raise [Seeking Alpha]
US:NASDAQ Investor Relations: delcath.com/investors
| IMPACT SNAPSHOT | EVENT TIME: | DCTH | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
DCTH alerts
DCTH alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DCTH alerts
High impacting Delcath Systems Inc news events
Weekly update
A roundup of the hottest topics
DCTH
NEWS
NEWS
- Delcath Announces Third Quarter Fiscal 2018 Financial Results[GlobeNewswire]
- Delcath files for $100M mixed shelf offering [Seeking Alpha][Seeking Alpha]
- Delcath Announces Enrollment of First Patient in ALIGN Trial[GlobeNewswire]
- CORRECTING and REPLACING – Delcath Expands Rollout of Registration Trial in Metastatic Ocular Melanoma[GlobeNewswire]
- Delcath adds six sites to study of Melphalan/HDS in ocular melanoma; shares ahead 2% [Seeking Alpha][Seeking Alpha]
- More
DCTH
SEC Filings
SEC Filings
- 11/30/18 - Form S-3/A
- 11/13/18 - Form 10-Q
- 11/9/18 - Form NT
- DCTH's page on the SEC website
- More